448 related articles for article (PubMed ID: 18953088)
1. Dopamine D1-like receptors agonist SKF 38393 increases cFOS expression in the paraventricular nucleus of the hypothalamus--impact of acute and chronic cocaine.
Chocyk A; Czyrak A; Wedzony K
J Physiol Pharmacol; 2008 Sep; 59(3):425-40. PubMed ID: 18953088
[TBL] [Abstract][Full Text] [Related]
2. Cooperative activation of D1-like and D2-like dopamine receptors in the nucleus accumbens shell is required for the reinstatement of cocaine-seeking behavior in the rat.
Schmidt HD; Pierce RC
Neuroscience; 2006 Oct; 142(2):451-61. PubMed ID: 16844308
[TBL] [Abstract][Full Text] [Related]
3. Effects of SKF-38393, a dopamine D1 receptor agonist on expression of amphetamine-induced behavioral sensitization and expression of immediate early gene arc in prefrontal cortex of rats.
Moro H; Sato H; Ida I; Oshima A; Sakurai N; Shihara N; Horikawa Y; Mikuni M
Pharmacol Biochem Behav; 2007 May; 87(1):56-64. PubMed ID: 17499349
[TBL] [Abstract][Full Text] [Related]
4. Comparison of interactions of D1-like agonists, SKF 81297, SKF 82958 and A-77636, with cocaine: locomotor activity and drug discrimination studies in rodents.
Chausmer AL; Katz JL
Psychopharmacology (Berl); 2002 Jan; 159(2):145-53. PubMed ID: 11862342
[TBL] [Abstract][Full Text] [Related]
5. The atypical dopamine D1 receptor agonist SKF 83959 induces striatal Fos expression in rats.
Wirtshafter D; Osborn CV
Eur J Pharmacol; 2005 Dec; 528(1-3):88-94. PubMed ID: 16324697
[TBL] [Abstract][Full Text] [Related]
6. Dopamine D1 receptor activation in the medial prefrontal cortex prevents the expression of cocaine sensitization.
Sorg BA; Li N; Wu WR
J Pharmacol Exp Ther; 2001 May; 297(2):501-8. PubMed ID: 11303036
[TBL] [Abstract][Full Text] [Related]
7. Effects of chronic administration of the D1 receptor partial agonist SKF 77434 on cocaine self-administration in rhesus monkeys.
Mutschler NH; Bergman J
Psychopharmacology (Berl); 2002 Apr; 160(4):362-70. PubMed ID: 11919663
[TBL] [Abstract][Full Text] [Related]
8. Modulation of heroin and cocaine self-administration by dopamine D1- and D2-like receptor agonists in rhesus monkeys.
Rowlett JK; Platt DM; Yao WD; Spealman RD
J Pharmacol Exp Ther; 2007 Jun; 321(3):1135-43. PubMed ID: 17351103
[TBL] [Abstract][Full Text] [Related]
9. Dissociation of cocaine-antagonist properties and motoric effects of the D1 receptor partial agonists SKF 83959 and SKF 77434.
Platt DM; Rowlett JK; Spealman RD
J Pharmacol Exp Ther; 2000 Jun; 293(3):1017-26. PubMed ID: 10869406
[TBL] [Abstract][Full Text] [Related]
10. Activation of dopamine D1 receptors in the medial prefrontal cortex produces bidirectional effects on cocaine-induced locomotor activity in rats: effects of repeated stress.
Sorg BA; Li N; Wu W; Bailie TM
Neuroscience; 2004; 127(1):187-96. PubMed ID: 15219681
[TBL] [Abstract][Full Text] [Related]
11. The role of dopamine receptor subtypes in the discriminative stimulus effects of amphetamine and cocaine in rats.
Filip M; Przegaliński E
Pol J Pharmacol; 1997; 49(1):21-30. PubMed ID: 9431548
[TBL] [Abstract][Full Text] [Related]
12. A comparison of the locomotor stimulant effects of D1-like receptor agonists in mice.
Desai RI; Terry P; Katz JL
Pharmacol Biochem Behav; 2005 Aug; 81(4):843-8. PubMed ID: 16000217
[TBL] [Abstract][Full Text] [Related]
13. Acute and repeated cocaine induces alterations in FosB/DeltaFosB expression in the paraventricular nucleus of the hypothalamus.
Chocyk A; Czyrak A; Wedzony K
Brain Res; 2006 May; 1090(1):58-68. PubMed ID: 16674926
[TBL] [Abstract][Full Text] [Related]
14. Behavioral effects of cocaine: interactions with D1 dopaminergic antagonists and agonists in mice and squirrel monkeys.
Katz JL; Kopajtic TA; Myers KA; Mitkus RJ; Chider M
J Pharmacol Exp Ther; 1999 Oct; 291(1):265-79. PubMed ID: 10490913
[TBL] [Abstract][Full Text] [Related]
15. Hippocampal modulation of locomotor activity induced by focal activation of postsynaptic dopamine receptors in the core of the nucleus accumbens.
Rouillon C; Abraini JH; David HN
Hippocampus; 2007; 17(11):1028-36. PubMed ID: 17604350
[TBL] [Abstract][Full Text] [Related]
16. Agonist efficacy and the behavioral effects of dopamine D1 receptor ligands: drug interaction studies in squirrel monkeys.
Bergman J; Spealman RD; Madras BK; Rosenzweig-Lipson S
J Pharmacol Exp Ther; 1996 Mar; 276(3):942-50. PubMed ID: 8786574
[TBL] [Abstract][Full Text] [Related]
17. Effects of selective D1- or D2-like dopamine receptor antagonists with acute "binge" pattern cocaine on corticotropin-releasing hormone and proopiomelanocortin mRNA levels in the hypothalamus.
Zhou Y; Spangler R; Yuferov VP; Schlussmann SD; Ho A; Kreek MJ
Brain Res Mol Brain Res; 2004 Nov; 130(1-2):61-7. PubMed ID: 15519677
[TBL] [Abstract][Full Text] [Related]
18. Anatomical localization of SKF-38393-induced behaviors in rats using the irreversible monoamine receptor antagonist EEDQ.
Neisewander JL; Ong A; McGonigle P
Synapse; 1995 Feb; 19(2):134-43. PubMed ID: 7725242
[TBL] [Abstract][Full Text] [Related]
19. Effects of dopamine D(1-like) and D(2-like) agonists in rats that self-administer cocaine.
Caine SB; Negus SS; Mello NK; Bergman J
J Pharmacol Exp Ther; 1999 Oct; 291(1):353-60. PubMed ID: 10490924
[TBL] [Abstract][Full Text] [Related]
20. Repeated intra-ventral tegmental area administration of SKF-38393 induces behavioral and neurochemical sensitization to a subsequent cocaine challenge.
Pierce RC; Born B; Adams M; Kalivas PW
J Pharmacol Exp Ther; 1996 Jul; 278(1):384-92. PubMed ID: 8764374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
